CoronavirusCovid-19Health

Md. Company Says Vaccine Shows Promise Against New Coronavirus Strains

Novovax, a Gaithersburg, Md.-based biotech company, says the coronavirus vaccine it is developing has shown signs of effectiveness against new, more contagious variants of the virus.

The company said in a statement Tuesday that its vaccine candidate demonstrated an 89.3% efficacy rate in its U.K. clinical trial, WUSA-TV (Channel 9) reported.

In addition, Novovax said its vaccine had a 95.6% efficacy rate against the original coronavirus strain and an efficacy rate of 85.6% against a new variant first found in the U.K.

But the company said its vaccine’s potency against another variant first found in South Africa is less than against the U.K. strain. In its South Africa Phase 2B trial, the efficacy rate was about 60%.

The company said its data suggests that those who’ve had coronavirus in the past may not be completely immune to the variant first found in South Africa, but that its vaccine provided “significant protection,” WUSA reported.

Three historically Black institutions — Howard University College of Medicine in Washington, D.C., Morehouse School of Medicine in Atlanta and Meharry Medical College in Nashville, Tennessee — are participating in Novovax’s clinical trials, aiming to encourage communities of color to get vaccinated.

As of Wednesday, roughly 56 million doses of coronavirus vaccines have been distributed nationwide, though only about 33.9 million have been administered, according to data from the Centers for Disease Control and Prevention.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Yes, I would like to receive emails from Washington Informer Newspaper. Sign me up!


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Adblock Detected

Please consider supporting us by disabling your ad blocker